company background image
SNDL

Sundial GrowersNasdaqCM:SNDL Stock Report

Market Cap

US$1.4b

7D

-7.2%

1Y

269.8%

Updated

25 Sep, 2021

Data

Company Financials +
SNDL fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance0/6
Financial Health5/6
Dividends0/6

SNDL Overview

Sundial Growers Inc. engages in production and marketing of cannabis products for the adult-use market in Canada.

Sundial Growers Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sundial Growers
Historical stock prices
Current Share PriceUS$0.67
52 Week HighUS$0.14
52 Week LowUS$3.96
Beta6.15
1 Month Change-13.25%
3 Month Change-30.62%
1 Year Change269.78%
3 Year Changen/a
5 Year Changen/a
Change since IPO-92.06%

Recent News & Updates

Shareholder Returns

SNDLUS PharmaceuticalsUS Market
7D-7.2%0.5%0.1%
1Y269.8%14.3%35.3%

Return vs Industry: SNDL exceeded the US Pharmaceuticals industry which returned 15.5% over the past year.

Return vs Market: SNDL exceeded the US Market which returned 37.5% over the past year.

Price Volatility

Is SNDL's price volatile compared to industry and market?
SNDL volatility
SNDL Beta6.15
Industry Beta0.64
Market Beta1

Stable Share Price: SNDL is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: SNDL's weekly volatility has decreased from 29% to 8% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006394Zach Georgehttps://www.sundialgrowers.com

Sundial Growers Inc. engages in production and marketing of cannabis products for the adult-use market in Canada. It produces and distributes inhalable products, such as flower, pre-rolls, and vapes. The company offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands.

Sundial Growers Fundamentals Summary

How do Sundial Growers's earnings and revenue compare to its market cap?
SNDL fundamental statistics
Market CapCA$1.76b
Earnings (TTM)-CA$322.15m
Revenue (TTM)CA$45.76m

38.5x

P/S Ratio

-5.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SNDL income statement (TTM)
RevenueCA$45.76m
Cost of RevenueCA$76.27m
Gross Profit-CA$30.51m
ExpensesCA$291.64m
Earnings-CA$322.15m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.16
Gross Margin-66.68%
Net Profit Margin-703.99%
Debt/Equity Ratio0%

How did SNDL perform over the long term?

See historical performance and comparison

Valuation

Is Sundial Growers undervalued compared to its fair value and its price relative to the market?

1.32x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: SNDL ($0.67) is trading above our estimate of fair value ($0.61)

Significantly Below Fair Value: SNDL is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: SNDL is unprofitable, so we can't compare its PE Ratio to the US Pharmaceuticals industry average.

PE vs Market: SNDL is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate SNDL's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: SNDL is good value based on its PB Ratio (1.3x) compared to the US Pharmaceuticals industry average (3.2x).


Future Growth

How is Sundial Growers forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

85.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SNDL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: SNDL is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: SNDL's is expected to become profitable in the next 3 years.

Revenue vs Market: SNDL's revenue (30.2% per year) is forecast to grow faster than the US market (9.8% per year).

High Growth Revenue: SNDL's revenue (30.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SNDL's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Sundial Growers performed over the past 5 years?

-50.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SNDL is currently unprofitable.

Growing Profit Margin: SNDL is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: SNDL is unprofitable, and losses have increased over the past 5 years at a rate of 50.5% per year.

Accelerating Growth: Unable to compare SNDL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SNDL is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (17.5%).


Return on Equity

High ROE: SNDL has a negative Return on Equity (-24.2%), as it is currently unprofitable.


Financial Health

How is Sundial Growers's financial position?


Financial Position Analysis

Short Term Liabilities: SNDL's short term assets (CA$1.1B) exceed its short term liabilities (CA$79.0M).

Long Term Liabilities: SNDL's short term assets (CA$1.1B) exceed its long term liabilities (CA$804.0K).


Debt to Equity History and Analysis

Debt Level: SNDL is debt free.

Reducing Debt: SNDL had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SNDL has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if SNDL has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is Sundial Growers's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate SNDL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SNDL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SNDL's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SNDL's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SNDL's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.5yrs

Average management tenure


CEO

Zach George (43 yo)

1.67yrs

Tenure

CA$9,223,965

Compensation

Mr. Zachary Ryan George, B.A, J.D., also known as Zach, is a Co-Founder, Managing Member, Partner and Portfolio Manager at FrontFour Capital Group LLC since 2006. Mr. George has been a Director of Sundial...


CEO Compensation Analysis

Compensation vs Market: Zach's total compensation ($USD7.27M) is above average for companies of similar size in the US market ($USD3.67M).

Compensation vs Earnings: Zach's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: SNDL's management team is considered experienced (2.5 years average tenure).


Board Members

Experienced Board: SNDL's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1324.4%.


Top Shareholders

Company Information

Sundial Growers Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Sundial Growers Inc.
  • Ticker: SNDL
  • Exchange: NasdaqCM
  • Founded: 2006
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$1.386b
  • Shares outstanding: 2.06b
  • Website: https://www.sundialgrowers.com

Number of Employees


Location

  • Sundial Growers Inc.
  • 919–11 Avenue SW
  • Suite 200
  • Calgary
  • Alberta
  • T2R 1P3
  • Canada

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/25 02:25
End of Day Share Price2021/09/24 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.